Influence of nutritional status and body composition on postoperative events and outcome in patients treated for primary localized retroperitoneal sarcoma
This work is licensed under the Creative Commons Attribution 4.0 International License.
Van Tine BA. 90 - Sarcomas of soft tissue. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, editors. Abeloff's clinical oncology (Sixth Edition). Philadelphia: Elsevier; 2019. p. 1655-93.e11.Van TineBA90 - Sarcomas of soft tissueIn:NiederhuberJEArmitageJOKastanMBDoroshowJHTepperJEeditors.Sixth EditionPhiladelphiaElsevier20191655-93.e11Search in Google Scholar
Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013; 49: 684–95. doi: 10.1016/j.ejca.2012.09.011StillerCATramaASerrainoDRossiSNavarroCChirlaqueMDDescriptive epidemiology of sarcomas in Europe: report from the RARECARE project2013496849510.1016/j.ejca.2012.09.011Open DOISearch in Google Scholar
Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA. The value of surgery for retroperitoneal sarcoma. Sarcoma 2009; 2009: 605840. doi: 10.1155/2009/605840GholamiSJacobsCDKappDSParastLMNortonJAThe value of surgery for retroperitoneal sarcoma2009200960584010.1155/2009/605840Open DOISearch in Google Scholar
Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2015; 22: 256–63. doi: 10.1245/s10434-014-3965-2Trans-Atlantic RPSWGManagement of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group2015222566310.1245/s10434-014-3965-2Open DOISearch in Google Scholar
Trans-Atlantic RPSWG. Erratum to: Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2017; 24: 688–9. doi: 10.1245/s10434-017-5889-0Trans-Atlantic RPSWGErratum to: Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group201724688910.1245/s10434-017-5889-0Open DOISearch in Google Scholar
Bonvalot S, Gronchi A, Le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2020; 21: 1366–77. doi: 10.1016/s1470-2045(20)30446-0BonvalotSGronchiALe PéchouxCSwallowCJStraussDMeeusPPreoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial20202113667710.1016/s1470-2045(20)30446-0Open DOISearch in Google Scholar
Bonvalot S, Gronchi A, Le Pechoux C, Swallow CJ, Strauss DC, Meeus P, et al. STRASS (EORTC 62092): a phase III randomized study of preoperative radio-therapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. [abstract]. J Clin Oncol 2019; 37(15 Sppl): 11001. doi: 10.1200/JCO.2019.37.15_suppl.11001BonvalotSGronchiALe PechouxCSwallowCJStraussDCMeeusPSTRASS (EORTC 62092): a phase III randomized study of preoperative radio-therapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. [abstract]20193715 Sppl1100110.1200/JCO.2019.37.15_suppl.11001Open DOISearch in Google Scholar
Callegaro D, Raut CP, Ajayi T, Strauss D, Bonvalot S, Ng D, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 Trial (STRASS) versus off-trial (STREXIT) results. Ann Surg 2023; 278: 127–34. doi: 10.1097/sla.0000000000005492CallegaroDRautCPAjayiTStraussDBonvalotSNgDPreoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 Trial (STRASS) versus off-trial (STREXIT) results20232781273410.1097/sla.0000000000005492Open DOISearch in Google Scholar
Bonvalot S, Raut CP, Pollock RE, Rutkowski P, Strauss DC, Hayes AJ, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012; 19: 2981–91. doi: 10.1245/s10434-012-2342-2BonvalotSRautCPPollockRERutkowskiPStraussDCHayesAJTechnical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG20121929819110.1245/s10434-012-2342-2Open DOISearch in Google Scholar
Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27: 31–7. doi: 10.1200/jco.2008.18.0802BonvalotSRivoireMCastaingMStoeckleELe CesneABlayJYPrimary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control20092731710.1200/jco.2008.18.0802Open DOISearch in Google Scholar
Gutierrez JC, Perez EA, Moffat FL, Livingstone AS, Franceschi D, Koniaris LG. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 2007; 245: 952–8. doi: 10.1097/01.sla.0000250438.04393.a8GutierrezJCPerezEAMoffatFLLivingstoneASFranceschiDKoniarisLGShould soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients2007245952810.1097/01.sla.0000250438.04393.a8Open DOISearch in Google Scholar
van Dalen T, Hennipman A, Van Coevorden F, Hoekstra HJ, van Geel BN, Slootweg P, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004; 11: 483–90. doi: 10.1245/aso.2004.09.005van DalenTHennipmanAVan CoevordenFHoekstraHJvan GeelBNSlootwegPEvaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma2004114839010.1245/aso.2004.09.005Open DOISearch in Google Scholar
Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, et al. ECCO Essential Requirements for Quality Cancer Care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol 2017; 110: 94–105. doi: 10.1016/j.critrevonc.2016.12.002AndritschEBeishonMBielackSBonvalotSCasaliPCrulMECCO Essential Requirements for Quality Cancer Care: soft tissue sarcoma in adults and bone sarcoma. A critical review20171109410510.1016/j.critrevonc.2016.12.002Open DOISearch in Google Scholar
Novak M, Perhavec A, Povšič M, Arnuš M, Eržen D. Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center. World J Surg Oncol 2020; 18: 277. doi: 10.1186/s12957-020-02038-9NovakMPerhavecAPovšičMArnušMErženDPrimary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center20201827710.1186/s12957-020-02038-9Open DOISearch in Google Scholar
Balderas-Pena LM, Gonzalez-Barba F, Martinez-Herrera BE, Palomares-Chacon UR, Duran-Anguiano O, Salazar-Paramo M, et al. Body composition and biochemical parameters of nutritional status: correlation with health-related quality of life in patients with colorectal cancer. Nutrients 2020; 12: 2110. doi: 10.3390/nu12072110Balderas-PenaLMGonzalez-BarbaFMartinez-HerreraBEPalomares-ChaconURDuran-AnguianoOSalazar-ParamoMBody composition and biochemical parameters of nutritional status: correlation with health-related quality of life in patients with colorectal cancer202012211010.3390/nu12072110Open DOISearch in Google Scholar
Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutri 2017; 36: 1187–96. doi: 10.1016/j.clnu.2017.06.017ArendsJBaracosVBertzHBozzettiFCalderPCDeutzNEPESPEN expert group recommendations for action against cancer-related malnutrition20173611879610.1016/j.clnu.2017.06.017Open DOISearch in Google Scholar
Kirov KM, Xu HP, Crenn P, Goater P, Tzanis D, Bouhadiba MT, et al. Role of nutritional status in the early postoperative prognosis of patients operated for retroperitoneal liposarcoma (RLS): a single center experience. Eur J Surg Oncol 2019; 45: 261–7. doi: 10.1016/j.ejso.2018.07.001KirovKMXuHPCrennPGoaterPTzanisDBouhadibaMTRole of nutritional status in the early postoperative prognosis of patients operated for retroperitoneal liposarcoma (RLS): a single center experience201945261710.1016/j.ejso.2018.07.001Open DOISearch in Google Scholar
Previtali P, Fiore M, Colombo J, Arendar I, Fumagalli L, Pizzocri M, et al. Malnutrition and perioperative nutritional support in retroperitoneal sarcoma patients: results from a prospective study. Ann Surg Oncol 2020; 27: 2025–32. doi: 10.1245/s10434-019-08121-0PrevitaliPFioreMColomboJArendarIFumagalliLPizzocriMMalnutrition and perioperative nutritional support in retroperitoneal sarcoma patients: results from a prospective study20202720253210.1245/s10434-019-08121-0Open DOISearch in Google Scholar
Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 2018; 23: 97–104. doi: 10.1634/theoncologist.2017-0255NippRDFuchsGEl-JawahriAMarioJTroschelFMGreerJASarcopenia is associated with quality of life and depression in patients with advanced cancer2018239710410.1634/theoncologist.2017-0255Open DOISearch in Google Scholar
Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2016; 17: 767.e1–7. doi: 10.1016/j.jamda.2016.05.016ChenLKLeeWJPengLNLiuLKAraiHAkishitaMRecent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia201617767.e1710.1016/j.jamda.2016.05.016Open DOISearch in Google Scholar
Czigany Z, Kramp W, Bednarsch J, van der Kroft G, Boecker J, Strnad P, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant 2020; 20: 493–503. doi: 10.1111/ajt.15577CziganyZKrampWBednarschJvan der KroftGBoeckerJStrnadPMyosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation20202049350310.1111/ajt.15577Open DOISearch in Google Scholar
Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, Rautio T, Ohtonen P, Saarnio J, et al. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study. Eur J Surg Oncol 2020; 46: 1656–62. doi: 10.1016/j.ejso.2020.03.206AroRMäkäräinen-UhlbäckEÄmmäläNRautioTOhtonenPSaarnioJThe impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study20204616566210.1016/j.ejso.2020.03.206Open DOISearch in Google Scholar
Rier HN, Jager A, Sleijfer S, Maier AB, Levin MD. The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature. Oncologist 2016; 21: 1396–409. doi: 10.1634/theoncologist.2016-0066RierHNJagerASleijferSMaierABLevinMDThe prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature201621139640910.1634/theoncologist.2016-0066Open DOISearch in Google Scholar
Deng CY, Lin YC, Wu JS, Cheung YC, Fan CW, Yeh KY, et al. Progressive sarcopenia in patients with colorectal cancer predicts survival. AJR Am J Roentgenol 2018; 210: 526–32. doi: 10.2214/ajr.17.18020DengCYLinYCWuJSCheungYCFanCWYehKYProgressive sarcopenia in patients with colorectal cancer predicts survival20182105263210.2214/ajr.17.18020Open DOISearch in Google Scholar
Jung AR, Roh JL, Kim JS, Kim SB, Choi SH, Nam SY, et al. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer. Eur J Cancer 2019; 116: 98–106. doi: 10.1016/j.ejca.2019.05.006JungARRohJLKimJSKimSBChoiSHNamSYPrognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer20191169810610.1016/j.ejca.2019.05.006Open DOISearch in Google Scholar
Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629–35. doi: 10.1016/S1470-2045(08)70153-0PradoCMLieffersJRMcCargarLJReimanTSawyerMBMartinLPrevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study200896293510.1016/S1470-2045(08)70153-0Open DOISearch in Google Scholar
Strassmann D, Hensen B, Grünwald V, Stange K, Eggers H, Länger F, et al. Impact of sarcopenia in advanced and metastatic soft tissue sarcoma. Int J Clin Oncol 2021; 26: 2151–60. doi: 10.1007/s10147-021-01997-7StrassmannDHensenBGrünwaldVStangeKEggersHLängerFImpact of sarcopenia in advanced and metastatic soft tissue sarcoma20212621516010.1007/s10147-021-01997-7Open DOISearch in Google Scholar
Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes 2014; 21: 345–51. doi: 10.1097/med.0000000000000093BaysHCentral obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction2014213455110.1097/med.0000000000000093Open DOISearch in Google Scholar
Boyle EA, Elliott JA, McIntyre TV, Barnes ME, Donlon NE, Umair M, et al. Body composition is associated with operative and oncologic outcomes in the management of retroperitoneal and trunk soft tissue sarcoma. Am J Surg 2022; 223: 729–37. doi: 10.1016/j.amjsurg.2021.08.005BoyleEAElliottJAMcIntyreTVBarnesMEDonlonNEUmairMBody composition is associated with operative and oncologic outcomes in the management of retroperitoneal and trunk soft tissue sarcoma20222237293710.1016/j.amjsurg.2021.08.005Open DOISearch in Google Scholar
O'Sullivan J, Lysaght J, Donohoe CL, Reynolds JV. Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments. Nat Rev Gastroenterol Hepatol 2018; 15: 699–714. doi: 10.1038/s41575-018-0069-7O'SullivanJLysaghtJDonohoeCLReynoldsJVObesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments20181569971410.1038/s41575-018-0069-7Open DOISearch in Google Scholar
Shirazipour CH, Freedland SJ. Obesity, visceral adiposity, and prostate cancer: what is the role of lifestyle interventions? Cancer 2019; 125: 2730–1. doi: 10.1002/cncr.32165ShirazipourCHFreedlandSJObesity, visceral adiposity, and prostate cancer: what is the role of lifestyle interventions?20191252730110.1002/cncr.32165Open DOISearch in Google Scholar
Baastrup NN, Christensen JK, Jensen KK, Jørgensen LN. Visceral obesity and short-term outcomes after laparoscopic rectal cancer resection. Surg Endosc 2020; 34: 177–85. doi: 10.1007/s00464-019-06748-4BaastrupNNChristensenJKJensenKKJørgensenLNVisceral obesity and short-term outcomes after laparoscopic rectal cancer resection2020341778510.1007/s00464-019-06748-4Open DOISearch in Google Scholar
Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev 2021; 22: e13088. doi: 10.1111/obr.13088SilveiraEAKliemannNNollMSarrafzadeganNde OliveiraCVisceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence202122e1308810.1111/obr.13088Open DOISearch in Google Scholar
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of skeletal muscle mass index, intramuscular adipose zissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation 2017; 101: 565–74. doi: 10.1097/tp.0000000000001587HamaguchiYKaidoTOkumuraSKobayashiAShiraiHYagiSImpact of skeletal muscle mass index, intramuscular adipose zissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation20171015657410.1097/tp.0000000000001587Open DOISearch in Google Scholar
Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, et al. Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma. Ann Surg Oncol 2016; 23: 1387–94. doi: 10.1245/s10434-015-5018-xOkamuraAWatanabeMMineSNishidaKImamuraYKurogochiTClinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma20162313879410.1245/s10434-015-5018-xOpen DOISearch in Google Scholar
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, et al. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer 2019; 8: 92–109. doi: 10.1159/000488779HamaguchiYKaidoTOkumuraSKobayashiAShiraiHYaoSPreoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma201989210910.1159/000488779Open DOISearch in Google Scholar
Grignol VP, Smith AD, Shlapak D, Zhang X, Del Campo SM, Carson WE. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy. Surg Oncol 2015; 24: 353–8. doi: 10.1016/j.suronc.2015.09.002GrignolVPSmithADShlapakDZhangXDel CampoSMCarsonWEIncreased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy201524353810.1016/j.suronc.2015.09.002Open DOISearch in Google Scholar
Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 2018; 29: ii1–9. doi: 10.1093/annonc/mdx810BaracosVEArribasLSarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy201829ii1910.1093/annonc/mdx810Open DOISearch in Google Scholar
Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 2022; 41: 990–1000. doi: 10.1016/j.clnu.2021.11.014DoniniLMBusettoLBischoffSCCederholmTBallesteros-PomarMDBatsisJADefinition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement202241990100010.1016/j.clnu.2021.11.014Open DOISearch in Google Scholar
Vehmas T, Kairemo KJ, Taavitsainen MJ. Measuring visceral adipose tissue content from contrast enhanced computed tomography. Int J Obes Relat Metab Disord 1996; 20: 570–3. PMID: 8782734VehmasTKairemoKJTaavitsainenMJMeasuring visceral adipose tissue content from contrast enhanced computed tomography1996205703PMID:8782734Search in Google Scholar
Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85: 115–22. doi: 10.1152/jappl.1998.85.1.115MitsiopoulosNBaumgartnerRNHeymsfieldSBLyonsWGallagherDRossRCadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography1998851152210.1152/jappl.1998.85.1.115Open DOISearch in Google Scholar
Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes 2007; 31: 500–6. doi: 10.1038/sj.ijo.0803454Maurovich-HorvatPMassaroJFoxCSMoselewskiFO'DonnellCJHoffmannUComparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography200731500610.1038/sj.ijo.0803454Open DOISearch in Google Scholar
Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997–1006. doi: 10.1139/H08-075MourtzakisMPradoCMLieffersJRReimanTMcCargarLJBaracosVEA practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care200833997100610.1139/H08-075Open DOISearch in Google Scholar
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13. doi: 10.1097/01.sla.0000133083.54934.aeDindoDDemartinesNClavienPAClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey20042402051310.1097/01.sla.0000133083.54934.aeOpen DOISearch in Google Scholar
Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37–42. doi: 10.1002/ijc.2910330108TrojaniMContessoGCoindreJMRouesseJBuiNBde MascarelASoft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system198433374210.1002/ijc.2910330108Open DOISearch in Google Scholar
Popuri K, Cobzas D, Esfandiari N, Baracos V, Jägersand M. Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle. IEEE Trans Med Imaging 2016; 35: 512–20. doi: 10.1109/tmi.2015.2479252PopuriKCobzasDEsfandiariNBaracosVJägersandMBody composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle2016355122010.1109/tmi.2015.2479252Open DOISearch in Google Scholar
Doyle SL, Bennett AM, Donohoe CL, Mongan AM, Howard JM, Lithander FE, et al. Establishing computed tomography – defined visceral fat area thresholds for use in obesity – related cancer research. Nutr Res 2013; 33: 171–9. doi: 10.1016/j.nutres.2012.12.007DoyleSLBennettAMDonohoeCLMonganAMHowardJMLithanderFEEstablishing computed tomography – defined visceral fat area thresholds for use in obesity – related cancer research201333171910.1016/j.nutres.2012.12.007Open DOISearch in Google Scholar
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 601. doi: 10.1093/ageing/afz046Cruz-JentoftAJBahatGBauerJBoirieYBruyereOCederholmTSarcopenia: revised European consensus on definition and diagnosis20194860110.1093/ageing/afz046Open DOISearch in Google Scholar
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489–95. doi: 10.1016/s1470-2045(10)70218-7FearonKStrasserFAnkerSDBosaeusIBrueraEFainsingerRLDefinition and classification of cancer cachexia: an international consensus2011124899510.1016/s1470-2045(10)70218-7Open DOISearch in Google Scholar
Contal C, O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 1999; 30: 253–70. doi: 10.1016/S0167-9473(98)00096-6ContalCO'QuigleyJAn application of changepoint methods in studying the effect of age on survival in breast cancer1999302537010.1016/S0167-9473(98)00096-6Open DOISearch in Google Scholar
Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev 2017; 26: 1008–15. doi: 10.1158/1055-9965.Epi-17-0200CaanBJMeyerhardtJAKroenkeCHAlexeeffSXiaoJWeltzienEExplaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study)20172610081510.1158/1055-9965.Epi-17-0200Open DOISearch in Google Scholar
Hassen W, Kassambara A, Reme T, Sahota S, Seckinger A, Vincent L, et al. Drug metabolism and clearance system in tumor cells of patients with multiple myeloma. Oncotarget 2015; 6: 6431–47. doi: 10.18632/oncotarget.3237HassenWKassambaraARemeTSahotaSSeckingerAVincentLDrug metabolism and clearance system in tumor cells of patients with multiple myeloma2015664314710.18632/oncotarget.3237Open DOISearch in Google Scholar
Kassambara A, Gourzones-Dmitriev C, Sahota S, Reme T, Moreaux J, Goldschmidt H, et al. A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy. Oncotarget 2014; 5: 2487–98. doi: 10.18632/oncotarget.1740KassambaraAGourzones-DmitrievCSahotaSRemeTMoreauxJGoldschmidtHA DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy2014524879810.18632/oncotarget.1740Open DOISearch in Google Scholar
He WZ, Jiang C, Liu LL, Yin CX, Rong YM, Hu WM, et al. Association of body composition with survival and inflammatory responses in patients with nonmetastatic nasopharyngeal cancer. Oral Oncology 2020; 108: 104771. doi: 10.1016/j.oraloncology.2020.104771HeWZJiangCLiuLLYinCXRongYMHuWMAssociation of body composition with survival and inflammatory responses in patients with nonmetastatic nasopharyngeal cancer202010810477110.1016/j.oraloncology.2020.104771Open DOISearch in Google Scholar
Caan BJ, Feliciano EMC, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol 2018; 4: 798–804. doi: 10.1001/jamaoncol.2018.0137CaanBJFelicianoEMCPradoCMAlexeeffSKroenkeCHBradshawPAssociation of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer2018479880410.1001/jamaoncol.2018.0137Open DOISearch in Google Scholar
Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992; 48: 73–85. doi: 10.2307/2532740LausenBSchumacherMMaximally selected rank statistics199248738510.2307/2532740Open DOISearch in Google Scholar
Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017; 36: 49–64. doi: 10.1016/j.clnu.2016.09.004CederholmTBarazzoniRAustinPBallmerPBioloGBischoffSCESPEN guidelines on definitions and terminology of clinical nutrition201736496410.1016/j.clnu.2016.09.004Open DOISearch in Google Scholar
Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 2015; 63: 131–40. doi: 10.1016/j.jhep.2015.02.031FujiwaraNNakagawaHKudoYTateishiRTaguriMWatadaniTSarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma2015631314010.1016/j.jhep.2015.02.031Open DOISearch in Google Scholar
McSorley ST, Black DH, Horgan PG, McMillan DC. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin Nutr 2018; 37: 1279–85. doi: 10.1016/j.clnu.2017.05.017McSorleySTBlackDHHorganPGMcMillanDCThe relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer20183712798510.1016/j.clnu.2017.05.017Open DOISearch in Google Scholar
Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539–47. doi: 10.1200/jco.2012.45.2722MartinLBirdsellLMacDonaldNReimanTClandininMTMcCargarLJCancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index20133115394710.1200/jco.2012.45.2722Open DOISearch in Google Scholar
Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 2020; 54: 237–46. doi: 10.2478/raon-2020-0016SrpcicMJordanTPopuriKSokMSarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer2020542374610.2478/raon-2020-0016Open DOISearch in Google Scholar
Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol 2020; 145: 102839. doi: 10.1016/j.critrevonc.2019.102839AleixoGFPShacharSSNyropKAMussHBMalpicaLWilliamsGRMyosteatosis and prognosis in cancer: systematic review and meta-analysis202014510283910.1016/j.critrevonc.2019.102839Open DOISearch in Google Scholar
Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001; 2: 141–7. doi: 10.1046/j.1467-789x.2001.00031.xPrenticeAMJebbSABeyond body mass index20012141710.1046/j.1467-789x.2001.00031.xOpen DOISearch in Google Scholar
Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Kamo N, et al. Impact of visceral adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases. World J Surg 2018; 42: 1180–91. doi: 10.1007/s00268-017-4255-5KobayashiAKaidoTHamaguchiYOkumuraSShiraiHKamoNImpact of visceral adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases20184211809110.1007/s00268-017-4255-5Open DOISearch in Google Scholar
Rickles AS, Iannuzzi JC, Mironov O, Deeb AP, Sharma A, Fleming FJ, et al. Visceral obesity and colorectal cancer: are we missing the boat with BMI? J Gastrointest Surg 2013; 17: 133–43; discussion p.43. doi: 10.1007/s11605-012-2045-9RicklesASIannuzziJCMironovODeebAPSharmaAFlemingFJVisceral obesity and colorectal cancer: are we missing the boat with BMI?20131713343discussion p.43.10.1007/s11605-012-2045-9Open DOISearch in Google Scholar
Smith AD, Gray MR, del Campo SM, Shlapak D, Ganeshan B, Zhang X, et al. Predicting overall survival in patients with metastatic melanoma on antiangiogenic therapy and RECIST stable disease on initial posttherapy images using CT texture analysis. AJR Am J Roentgenol 2015; 205: W283–93. doi: 10.2214/ajr.15.14315SmithADGrayMRdel CampoSMShlapakDGaneshanBZhangXPredicting overall survival in patients with metastatic melanoma on antiangiogenic therapy and RECIST stable disease on initial posttherapy images using CT texture analysis2015205W2839310.2214/ajr.15.14315Open DOISearch in Google Scholar
Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015; 157: 1088–98. doi: 10.1016/j.surg.2015.02.002OkumuraSKaidoTHamaguchiYFujimotoYMasuiTMizumotoMImpact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer201515710889810.1016/j.surg.2015.02.002Open DOISearch in Google Scholar
He AQ, Li CQ, Zhang Q, Liu T, Liu J, Liu G. Visceral-to-subcutaneous fat ratio is a potential predictor of postoperative complications in colorectal cancer. Med Sci Monit 2021; 27: e930329. doi: 10.12659/msm.930329HeAQLiCQZhangQLiuTLiuJLiuGVisceral-to-subcutaneous fat ratio is a potential predictor of postoperative complications in colorectal cancer202127e93032910.12659/msm.930329Open DOISearch in Google Scholar
Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7: 410–20. doi: 10.1016/j.cmet.2008.04.004TranTTYamamotoYGestaSKahnCRBeneficial effects of subcutaneous fat transplantation on metabolism200874102010.1016/j.cmet.2008.04.004Open DOISearch in Google Scholar
Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, et al. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer 2017; 117: 148–55. doi: 10.1038/bjc.2017.149EbadiMMartinLGhoshSFieldCJLehnerRBaracosVESubcutaneous adiposity is an independent predictor of mortality in cancer patients20171171485510.1038/bjc.2017.149Open DOISearch in Google Scholar
Ebadi M, Baracos VE, Bathe OF, Robinson LE, Mazurak VC. Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content. Clin Nutr 2016; 35: 1347–53. doi: 10.1016/j.clnu.2016.02.014EbadiMBaracosVEBatheOFRobinsonLEMazurakVCLoss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content20163513475310.1016/j.clnu.2016.02.014Open DOISearch in Google Scholar
Di Prata C, Renouf B, Tzanis D, Bouhadiba T, Watson S, Zein SE, et al. Significant predictors of postoperative morbidity after radical resection of retroperitoneal sarcoma in a tertiary center. Ann Surg Oncol 2023; 30: 4515–26. doi: 10.1245/s10434-023-13459-7Di PrataCRenoufBTzanisDBouhadibaTWatsonSZeinSESignificant predictors of postoperative morbidity after radical resection of retroperitoneal sarcoma in a tertiary center20233045152610.1245/s10434-023-13459-7Open DOISearch in Google Scholar
Nasirishargh A, Grova M, Bateni CP, Judge SJ, Nuno MA, Basmaci UN, et al. Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma. J Surg Oncol 2023; 127: 855–61. doi: 10.1002/jso.27199NasirisharghAGrovaMBateniCPJudgeSJNunoMABasmaciUNSarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma20231278556110.1002/jso.27199Open DOISearch in Google Scholar
Choi ES, Kim HS, Han I. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma. Ann Surg Oncol 2014; 21: 778–85. doi: 10.1245/s10434-013-3418-3ChoiESKimHSHanIElevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma2014217788510.1245/s10434-013-3418-3Open DOISearch in Google Scholar
Fiore M, Ljevar S, Pasquali S, Morelli D, Callegaro D, Sanfilippo R, et al. Preoperative neutrophil-to-lymphocyte ratio and a new inflammatory biomarkers prognostic index for primary retroperitoneal sarcomas: retrospective monocentric study. Clin Cancer Res 2023; 29: 614–20. doi: 10.1158/1078-0432.CCR-22-2897FioreMLjevarSPasqualiSMorelliDCallegaroDSanfilippoRPreoperative neutrophil-to-lymphocyte ratio and a new inflammatory biomarkers prognostic index for primary retroperitoneal sarcomas: retrospective monocentric study2023296142010.1158/1078-0432.CCR-22-2897Open DOISearch in Google Scholar
Schwartz PB, Poultsides G, Roggin K, Howard JH, Fields RC, Clarke CN, et al. PLR and NLR are poor predictors of survival outcomes in sarcomas: a new perspective from the USSC. J Surg Res 2020; 251: 228–38. doi: 10.1016/j.jss.2020.01.008SchwartzPBPoultsidesGRogginKHowardJHFieldsRCClarkeCNPLR and NLR are poor predictors of survival outcomes in sarcomas: a new perspective from the USSC20202512283810.1016/j.jss.2020.01.008Open DOISearch in Google Scholar
Netanyahu Y, Gerstenhaber F, Shamai S, Sher O, Merimsky O, Klausner JM, et al. Innate inflammatory markers for predicting survival in retroperitoneal sarcoma. J Surg Oncol 2020; 122: 1655–61. doi: 10.1002/jso.26178NetanyahuYGerstenhaberFShamaiSSherOMerimskyOKlausnerJMInnate inflammatory markers for predicting survival in retroperitoneal sarcoma202012216556110.1002/jso.26178Open DOISearch in Google Scholar
Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Desai A, Gladdy RA, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic australasian RPS Working Group. Ann Surg Oncol 2021; 28: 7873–88. doi: 10.1245/s10434-021-09654-zSwallowCJStraussDCBonvalotSRutkowskiPDesaiAGladdyRAManagement of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic australasian RPS Working Group20212878738810.1245/s10434-021-09654-zOpen DOISearch in Google Scholar
Fearon KC, Luff R. The nutritional management of surgical patients: enhanced recovery after surgery. Proc Nutr Soc 2003; 62: 807–11. doi: 10.1079/PNS2003299FearonKCLuffRThe nutritional management of surgical patients: enhanced recovery after surgery2003628071110.1079/PNS2003299Open DOISearch in Google Scholar